Bert Oehlen Selected Research

(5- fluoro- 2- methyl- 1- (3,5- dimethoxy- 4- hydroxybenzylidene)- 3- (N- benzyl)indene)acetamide

1/2006

The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bert Oehlen Research Topics

Disease

2	Colonic Neoplasms (Colon Cancer) 01/2006 - 09/2005
1	Neoplasms (Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

2	sulindac sulfone (exisulind)IBA 01/2006 - 09/2005
2	(5- fluoro- 2- methyl- 1- (4- pyridyl)methylene- 3- (N- benzyl)- indene)- acetamide hydrochlorideIBA 01/2006 - 09/2005
2	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2006 - 09/2005
1	Sulindac (Copal)FDA LinkGeneric 01/2006
1	(5- fluoro- 2- methyl- 1- (3,5- dimethoxy- 4- hydroxybenzylidene)- 3- (N- benzyl)indene)acetamideIBA 01/2006
1	Cyclic GMPIBA 09/2005
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 09/2005
1	AcidsIBA 09/2005